Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl

Clinical trial NCT01081132 · COMPLETED

Trial details

NCT number: NCT01081132
Sponsor: Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder

Start date: 2011-09-19
Primary completion: 2013-05-16
Enrollment: 314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.